64 research outputs found
Russian version of cultural federalism
This article proposes a vision of the idea of βcultural federalismβ contributing to the stability of ethnic culture in the era of assimilation by mass culture and global unification, revitalizing the meanings of modernity, enriching the multinational synergy of Russian culture, overcoming capitalist alienation and disintegration of multiculturalism. Methods of analysis and comparison are used in ethnocultural dynamics, mastering such symbolic conquests as βfederalismβ in the paradigm of modernity, which fits into the process of ethnocultural modernization.
The novelty of the work lies in the substantiation of the concept of cultural federalism vs ethnic federalism, as the most appropriate for the modern cultural situation in Russia, the cultural capital of which is multinational and, accordingly, the effect of βRussian multiculturalismβ that can oppose secession with an integration trend, reanimate the cooperative effect of the interaction of cultural programs, their complementarity.
The authors are interested in the dialectical self-development of historical and cultural differences of the subjects of the federation entering the era of natural modernization, reflected in the ethnic cultural renaissance of the present. The idea of cultural federalism contributes to the development of the Russian national idea, the absence of which reduces the effect of national consolidation and socio-economic development. It is proposed as a tool for solving the problem of "sleeping federalism" and the dialectical contradiction between the form and content of the present state of ethnic federalism
SOCIAL INTERACTION OF LARGE BUSINESSES AS A SECURITY CONDITION OF ITS OPERATION AND DEVELOPMENT IN THE NORTHERN REGION
Purpose: The aim of the research is to identify social interaction of large businesses as a security condition of its operation and development in the northern region.
Methodology: This is descriptive-analytic research whose data are obtained through library studies and analytical resources. Data analysis is based on content analysis and analytical comparison.
Result: Results showed that to improve the safety of large businesses in the Northern region continuous socially-oriented activities aimed at improving the quality of life of the population of the region of presence with the support of various social initiatives in the region of presence are required.
Applications: This research can be used for businessmen and developers.
Novelty/Originality: In this research, the model of social interaction of large businesses is presented in a comprehensive and complete manner
The sphericity of erythrocytes and its communication with biochemical, hemostasis and rheological by properties of blood at the patients with coronary disease and arterial hypertension
The aim of the work was to study the peculiarities of the influence of bloodfactors on the development of spherocytosis in patients with coronary disease and arterial hypertension. The study involved 30 patients with coronary disease and 24 patients arterial hypertension with the study of their clinical status and biochemical parameters of blood, hemostasis, blood cell analysis. It was found that the increase in the pool spherocytic cells in patients with arterial hypertension were associated with increased nitric oxide production, while in patients with coronary disease spherocytosis was due to an increase in the concentration of reactive oxygen metabolites
SOME ASPECTS OF THE ESTIMATION OF STRUCTURAL-FUNCTIONAL CHANGES IN MEMBRANE OF ERYTHROCYTES AT THE CARDIOVASCULAR PATHOLOGY
The article presents the estimation of structural-functional changes in erythrocytic membranes accompanied with the change of activity of different enzymes that determine normal functioning of erythrocytes. Change of lipid-protein and protein-protein interactions causes the reapportionment of charges on the surface of erythrocytes and. the decrease of total charge of cell and. leads to the increase of aggregation of erythrocytes and. the change of rheological properties of blood. In the end. it reflects on the effectiveness of oxygen transportation, transcapillary diffusion and perfusion of blood in microcirculation channel
Dysfunction of vascular endothelium at arterial hypertension and coronary disease (literature review)
This review presents the observation of the role of endothelial dysfunction in development of atherosclerosis, coronary disease and. hypertension. Among other causes of endothelial dysfunction the most significant are hemodynamic factors (wall transverse strain, transmural pressure), dyslipoproteinemia, hyperhomocysteinemia, hyperglycemia, free radical damage of endothelium. It is supposed that in development and. progressing of coronary disease more significant role may belong to endothelial dysfunction rather than to morphological vascular changes, predetermined by atherosclerosis. However, there is still no clear view of development of endothelial dysfunction and. mechanisms of development and. progressing of both isolated forms of coronary disease and arterial hypertension and their combination
PROTEINS OF THE ERYTHROCYTE MEMBRANE AND METABOLIC SYNDROME
There is no literature data on the changes of structural and functional qualities of the erythrocyte membrane at the arterial hypertension (AH) complicated and non-complicated by the metabolic syndrome (MS). Although the changes of interrelation between the proteins of erythrocyte membrane at the AH can influence the deformability of the membrane itself. The aim of the work was to estimate the peculiarities of interrelation between the proteins of erythrocyte membrane in the patients with arterial hypertension complicated and non-complicated by the metabolic syndrome. The research included 51 men with AH and 29 clinically healthy men which were divided into 3 groups: group 1 - control; group 2 - men with AH complicated with MS (n = 29); group 3 - men with AH non-complicated with MS (n = 22). We studied blood lipids, biochemical and hemostasiological parameters, assessed 10 proteins of erythrocyte membrane. Patients of the 2nd and 3rd groups had different content of Ξ±- and Ξ²-spectrins, anion-transport protein (ATP), plates 4.1, glycerol-3-phosphatededehydrogenase (G-3-PDG), glutathione S-transferase (GST). The results of the research showed that metabolic syndrome at the AH can not only influence the state of vessel wall but also cause significant disorders of structural and functional qualities of the erythrocyte membrane
Level of membrane-bound hemoglobin and red-cell membrane proteins in patients with essential hypertension complicated and not complicated with metabolic syndrome
We studied the effect of different levels of membrane-bound hemoglobin on the level of red-cell membrane proteins and also their interrelation in patients with essential hypertension with and without metabolic syndrome. It wasfound that high membrane-bound hemoglobin is closely related to the low level of high-density lipoproteins and high level of low-density lipoproteins in patients with essential hypertension complicated with metabolic syndrome. In patients with essential hypertension not complicated with metabolic syndrome high membrane-bound hemoglobin is related to the increased prothrombin time and decreased blood urea nitrogen. In patients with essential hypertension complicated with metabolic syndrome high membrane-bound hemoglobin significantly influences the level of membrane contractile proteins (actin, tropomiosine). In patients with essential hypertension without metabolic syndrome high membrane-bound hemoglobin is accompanied by the decrease of structural and integral membrane proteins levels (anion-transport protein and protein 4.1). As the result of quantitative changes in these proteins and change in their interrelations in patients with ssential hypertension complicated with metabolic syndrome more intensive disorders of structural and functional organization of red-cell membrane can appear
ΠΡΠ΅Π½ΠΊΠ° ΡΡΠΆΠ΅ΡΡΠΈ ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠ°ΡΠΊΠ΅ΡΡ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΡΡ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ Π΄ΡΡ Π°Π½ΠΈΡ Π²ΠΎ Π²ΡΠ΅ΠΌΡ ΡΠ½Π°
The methods of variation statistics (discriminant, cluster, factor, correlation and regression analyses) were used to determine: 1) the optimal gradation of apnea/hypopnea index (AHI) in order to detect the severity of obstructive sleep disordered breathing (OSDB) and 2) the most representative OSDB clinical markers. Clinical features of OSDB and parameters of nocturnal cardiorespiratory monitoring were analysed in 115 patients of cardiological inpatient department (80 men, 35 women aged 54.6Β±10.8 years). During nocturnal cardiorespiratory monitoring OSDB with average AHI 23.0Β±19.4/h was revealed in 105 (91.3%) patients.The results show that the optimal determination of sleep apnea-hypopnea syndrome severity includes the following gradation of AHI: mild - from 5 to 20/hr. moderate β from 20 to 40/hr, severe β >40/hr. To avoid clinical errors it is also necessary in some cases to take into account the duration of apnea/hypopnea events, index of arousal and desaturation degree. The most significant OSDB clinical markers with AHI>5/hr include snore (sensitivity 88%, specificity 100%), BMI>30kg/m2 (80% and 90% respectively) and rates higher than 5 according to the Epworth sleepiness scale (65% and 77% respectively). Risk for OSDB increases rapidly at BMI>25kg/m2 and sleepiness rate >5 according to Epworth scale. BMI>37kg/m2 and sleeping rate >10 according to Epworth scale were often associated with severe (AHI>40/hr) sleep apnea/hypopnea syndrome.ΠΠ΅ΡΠΎΠ΄Ρ Π²Π°ΡΠΈΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΡΠ°ΡΠΈΡΡΠΈΠΊΠΈ (Π΄ΠΈΡΠΊΡΠΈΠΌΠΈΠ½Π°Π½ΡΠ½ΡΠΉ, ΠΊΠ»Π°ΡΡΠ΅ΡΠ½ΡΠΉ, ΡΠ°ΠΊΡΠΎΡΠ½ΡΠΉ ΠΈ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΎΠ½Π½ΠΎΡΠ΅Π³ΡΠ΅ΡΡΠΈΠΎΠ½Π½ΡΠΉ Π°Π½Π°Π»ΠΈΠ·) ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½Ρ Π΄Π»Ρ Π²ΡΠ±ΠΎΡΠ° ΠΎΠΏΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΉ Π³ΡΠ°Π΄Π°ΡΠΈΠΈ ΠΈΠ½Π΄Π΅ΠΊΡΠ° Π°ΠΏΠ½ΠΎΡ/Π³ΠΈΠΏΠΎΠΏΠ½ΠΎΡ (ΠΠΠ) ΠΏΡΠΈ ΠΎΡΠ΅Π½ΠΊΠ΅ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΡΡΠΆΠ΅ΡΡΠΈ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΡΡ
Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ Π΄ΡΡ
Π°Π½ΠΈΡ Π²ΠΎ Π²ΡΠ΅ΠΌΡ ΡΠ½Π° (ΠΠΠΠ‘) ΠΈ Π΄Π»Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠ²Π½ΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΠΠΠΠ‘. ΠΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π½ΠΎΡΠ½ΠΎΠ³ΠΎ ΠΊΠ°ΡΠ΄ΠΈΠΎΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ Ρ 115 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ° (80 ΠΌΡΠΆΡΠΈΠ½, 35 ΠΆΠ΅Π½ΡΠΈΠ½, ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ 54,6Β±10,8 Π³ΠΎΠ΄Π°). ΠΡΠΈ ΠΊΠ°ΡΠ΄ΠΈΠΎΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΌ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΠΠΠΠ‘ (ΡΡΠ΅Π΄Π½ΠΈΠΉ ΠΠΠ 23,0Β±19,4/ΡΠ°Ρ) Π±ΡΠ»ΠΈ Π²ΡΡΠ²Π»Π΅Π½Ρ Ρ 105 (91,3%) ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ².Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ, ΡΡΠΎ Π΄Π»Ρ ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π°ΠΏΠ½ΠΎΡ/Π³ΠΈΠΏΠΎΠΏΠ½ΠΎΡ ΡΠ½Π° Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΠΎΠΏΡΠΈΠΌΠ°Π»ΡΠ½ΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°ΡΡ ΡΠ»Π΅Π΄ΡΡΡΡΡ Π³ΡΠ°Π΄Π°ΡΠΈΡ ΠΠΠ: Π»Π΅Π³ΠΊΠ°Ρ ΡΡΠ΅ΠΏΠ΅Π½Ρ β ΠΎΡ 5 Π΄ΠΎ 20/ΡΠ°Ρ, ΡΡΠ΅Π΄Π½ΡΡ β ΠΎΡ 20 Π΄ΠΎ 40/ΡΠ°Ρ, ΡΡΠΆΠ΅Π»Π°Ρ β Π±ΠΎΠ»Π΅Π΅ 40/ΡΠ°Ρ. Π§ΡΠΎΠ±Ρ ΠΈΠ·Π±Π΅ΠΆΠ°ΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΡΠΈΠ±ΠΎΠΊ, Π² ΡΡΠ΄Π΅ ΡΠ»ΡΡΠ°Π΅Π² ΡΠ»Π΅Π΄ΡΠ΅Ρ ΡΠ°ΠΊΠΆΠ΅ ΠΏΡΠΈΠ½ΠΈΠΌΠ°ΡΡ Π²ΠΎ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΡΠΏΠΈΠ·ΠΎΠ΄ΠΎΠ² Π°ΠΏΠ½ΠΎΡ/Π³ΠΈΠΏΠΎΠΏΠ½ΠΎΡ, ΠΈΠ½Π΄Π΅ΠΊΡ ΡΠ΅Π°ΠΊΡΠΈΠΉ ΠΠΠ Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ ΠΈ ΡΡΠ΅ΠΏΠ΅Π½Ρ Π΄Π΅ΡΠ°ΡΡΡΠ°ΡΠΈΠΈ. ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π·Π½Π°ΡΠΈΠΌΡΠΌΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΌΠ°ΡΠΊΠ΅ΡΠ°ΠΌΠΈ ΠΠΠΠ‘ ΠΏΡΠΈ ΠΠΠ>5/ΡΠ°Ρ ΡΠ²Π»ΡΡΡΡΡ Ρ
ΡΠ°ΠΏ (ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ 88%, ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΎΡΡΡ 100%), ΠΈΠ½Π΄Π΅ΠΊΡ ΠΌΠ°ΡΡΡ ΡΠ΅Π»Π° (ΠΠΠ’) Π±ΠΎΠ»Π΅Π΅ 30 ΠΊΠ³/ΠΌ2 (80% ΠΈ 90% ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ) ΠΈ Π΄Π½Π΅Π²Π½Π°Ρ ΡΠΎΠ½Π»ΠΈΠ²ΠΎΡΡΡ (ΠΠ‘) Π±ΠΎΠ»Π΅Π΅ 5 Π±Π°Π»Π»ΠΎΠ² ΠΏΠΎ ΡΠΊΠ°Π»Π΅ ΠΡworth (65% ΠΈ 77% ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ). Π ΠΈΡΠΊ Π½Π°Π»ΠΈΡΠΈΡ ΠΠΠΠ‘ Π½Π°ΡΠ°ΡΡΠ°Π΅Ρ ΠΏΡΠΈ ΠΠΠ’>25 ΠΊΠ³/ΠΌ2 ΠΈ ΠΠ‘>5 Π±Π°Π»Π»ΠΎΠ² ΠΏΠΎ ΡΠΊΠ°Π»Π΅ ΠΡworth ΠΏΡΠΈ ΡΡΠΎΠΌ Π·Π½Π°ΡΠ΅Π½ΠΈΡ ΠΠΠ’>37 ΠΊΠ³/ΠΌ2 ΠΈ ΠΠ‘>10 Π±Π°Π»Π»ΠΎΠ² ΠΎΠ±ΡΡΠ½ΠΎ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°ΡΡΡΡ ΡΡΠΆΠ΅Π»ΡΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠΌ Π°ΠΏΠ½ΠΎΡ/Π³ΠΈΠΏΠΎΠΏΠ½ΠΎΡ ΡΠ½Π° Ρ ΠΠΠ>40/ΡΠ°Ρ
Neurotoxic complications of chemotherapy in children: posterior reversible encephalopathy syndrome
The aim of the study was to present the clinical-radiological aspect of the syndrome of posterior reversible encephalopathy in children with oncological diseasesΠ¦Π΅Π»Ρ ΠΏΡΠ±Π»ΠΈΠΊΠ°ΡΠΈΠΈ β ΠΏΡΠ΅Π΄ΡΡΠ°Π²ΠΈΡΡ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΡΠ°Π΄ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΡΡ ΠΊΠ°ΡΡΠΈΠ½Ρ ΠΎΠ±ΡΠ°ΡΠΈΠΌΠΎΠΉ ΡΠ½ΡΠ΅ΡΠ°Π»ΠΎΠΏΠ°ΡΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌ
- β¦